Clinical Trials on Hepatocellular Carcinoma; Targeted Therapy; Progression-free Survival in Germany

Total 2 results

iOMEDICO AG
Novartis

Completed

Open Label, Single Arm Trial to Characterize Patients With Metastatic RCC Treated With Everolimus After Failure of the First VEGF-targeted Therapy (MARC-2) (MARC-2)

Metastatic Renal Cell Carcinoma | Failure of Exactly One Prior VEGF-targeted Therapy

Germany
Ludwig-Maximilians - University of Munich

Recruiting

Prospective Observational Trial to Evaluate Quality of Life After Stereotactic Ablative Radiation Therapy in Patients With Hepatocellular Carcinoma (LIVERCARE)

Quality of Life | Hepatocellular Cancer | Stereotactic Body Radiation Therapy | Observational

Germany

3

Subscribe